Company Data
Enlivex Therapeutics Ltd.
Ticker
ENLV
Current Price
$4.68 -1.47%
Market Cap
$78.8M
Price Target
Refer to Report
Volume
118.2K
52wk Range
$4.735 - $31.5
Overview
Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company’s Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system’s own natural regulation mechanisms.